• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Molecular Docking: From Lock and Key to Combination Lock.分子对接:从锁钥模型到组合锁模型
J Mol Med Clin Appl. 2017;2(1). doi: 10.16966/2575-0305.106. Epub 2017 Feb 10.
2
Advances in Docking.对接技术的新进展。
Curr Med Chem. 2019;26(42):7555-7580. doi: 10.2174/0929867325666180904115000.
3
Machine learning in computational docking.计算对接中的机器学习。
Artif Intell Med. 2015 Mar;63(3):135-52. doi: 10.1016/j.artmed.2015.02.002. Epub 2015 Feb 16.
4
Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches.通过多电子药效团、基于配体的药效团、分子对接和密度泛函理论方法鉴定选择性 MMP-9 抑制剂。
J Biomol Struct Dyn. 2019 Mar;37(4):944-965. doi: 10.1080/07391102.2018.1444510. Epub 2018 Mar 9.
5
Molecular Modeling Studies of Novel Fluoroquinolone Molecules.新型氟喹诺酮类分子的分子模拟研究
Curr Drug Discov Technol. 2018;15(2):109-122. doi: 10.2174/1570163814666170829142044.
6
Exploration of New and Potent Lead Molecules Against CAAX Prenyl Protease I of Leishmania donovani Through Pharmacophore Based Virtual Screening Approach.通过基于药效团的虚拟筛选方法探索针对杜氏利什曼原虫CAAX异戊二烯基蛋白酶I的新型强效先导分子。
Comb Chem High Throughput Screen. 2017;20(3):255-271. doi: 10.2174/1386207320666170120164515.
7
Pharmacophore modeling and virtual screening in search of novel Bruton's tyrosine kinase inhibitors.基于药效团模型的虚拟筛选寻找新型布鲁顿酪氨酸激酶抑制剂
J Mol Model. 2019 Jun 6;25(7):179. doi: 10.1007/s00894-019-4047-y.
8
Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2 Predicted by 3D QSAR Pharmacophore Models, Molecular Docking and Evolution.通过 3D QSAR 药效团模型、分子对接和进化预测发现新型 DPP-IV 抑制剂,作为 2 型糖尿病治疗的潜在候选药物。
Molecules. 2019 Aug 7;24(16):2870. doi: 10.3390/molecules24162870.
9
Virtual Screening of Novel Glucosamine-6-Phosphate Synthase Inhibitors.新型6-磷酸葡萄糖胺合酶抑制剂的虚拟筛选
Comb Chem High Throughput Screen. 2018;21(3):182-193. doi: 10.2174/1386207321666180330114457.
10
Molecular Docking, Molecular Dynamics, and Structure-Activity Relationship Explorations of 14-Oxygenated N-Methylmorphinan-6-ones as Potent μ-Opioid Receptor Agonists.14-氧化N-甲基吗啡喃-6-酮作为强效μ-阿片受体激动剂的分子对接、分子动力学及构效关系研究
ACS Chem Neurosci. 2017 Jun 21;8(6):1327-1337. doi: 10.1021/acschemneuro.6b00460. Epub 2017 Feb 9.

引用本文的文献

1
Molecule generation for target protein binding with hierarchical consistency diffusion model.用于与目标蛋白结合的分子生成的分层一致性扩散模型。
Chem Sci. 2025 Sep 2. doi: 10.1039/d5sc02113h.
2
Binding Affinity Determination in Drug Design: Insights from Lock and Key, Induced Fit, Conformational Selection, and Inhibitor Trapping Models.药物设计中的结合亲和力测定:锁钥、诱导契合、构象选择和抑制剂捕获模型的见解。
Int J Mol Sci. 2024 Jun 28;25(13):7124. doi: 10.3390/ijms25137124.
3
ATOMDANCE: Kernel-based denoising and choreographic analysis for protein dynamic comparison.ATOMDANCE:基于核的去噪和编舞分析,用于蛋白质动态比较。
Biophys J. 2024 Sep 3;123(17):2705-2715. doi: 10.1016/j.bpj.2024.03.024. Epub 2024 Mar 21.
4
A flexible data-free framework for structure-based drug design with reinforcement learning.一种用于基于结构的药物设计的灵活的无数据强化学习框架。
Chem Sci. 2023 Oct 19;14(43):12166-12181. doi: 10.1039/d3sc04091g. eCollection 2023 Nov 8.
5
Theoretical study of ArcB and its dimerization, interaction with anaerobic metabolites, and activation of ArcA.ArcB 及其二聚化、与厌氧代谢物相互作用以及激活 ArcA 的理论研究。
PeerJ. 2023 Oct 13;11:e16309. doi: 10.7717/peerj.16309. eCollection 2023.
6
Anti-inflammatory and Antiphytopathogenic Fungal Activity of 2,3--Tirucallane Triterpenoids Meliadubins A and B from Cav. Barks with ChemGPS-NP and In Silico Prediction.利用ChemGPS-NP和计算机模拟预测从卡瓦树皮中提取的2,3-羽扇豆烷三萜类化合物Meliadubins A和B的抗炎及抗植物病原真菌活性
ACS Omega. 2023 Sep 27;8(40):37116-37127. doi: 10.1021/acsomega.3c04657. eCollection 2023 Oct 10.
7
An equivariant generative framework for molecular graph-structure Co-design.用于分子图结构协同设计的等变生成框架。
Chem Sci. 2023 Jul 19;14(31):8380-8392. doi: 10.1039/d3sc02538a. eCollection 2023 Aug 9.
8
CSI: Contrastive data Stratification for Interaction prediction and its application to compound-protein interaction prediction.CSI:用于交互预测的对比数据分层及其在化合物-蛋白质相互作用预测中的应用。
Bioinformatics. 2023 Aug 1;39(8). doi: 10.1093/bioinformatics/btad456.
9
Biochar-extracted liquor stimulates nitrogen related gene expression on improving nitrogen utilization in rice seedling.生物炭提取液通过刺激氮相关基因表达来提高水稻幼苗的氮利用率。
Front Plant Sci. 2023 Jun 19;14:1131937. doi: 10.3389/fpls.2023.1131937. eCollection 2023.
10
Structure-Based Design of Novel MAO-B Inhibitors: A Review.基于结构的新型 MAO-B 抑制剂设计:综述。
Molecules. 2023 Jun 16;28(12):4814. doi: 10.3390/molecules28124814.

本文引用的文献

1
An all atom force field for simulations of proteins and nucleic acids.一种用于蛋白质和核酸模拟的全原子力场。
J Comput Chem. 1986 Apr;7(2):230-252. doi: 10.1002/jcc.540070216.
2
Virtual Screening for HIV Protease Inhibitors Using a Novel Database Filtering Procedure.使用新型数据库筛选程序进行HIV蛋白酶抑制剂的虚拟筛选
Mol Inform. 2015 Jun;34(6-7):485-92. doi: 10.1002/minf.201400170. Epub 2015 Jun 22.
3
Machine learning in computational docking.计算对接中的机器学习。
Artif Intell Med. 2015 Mar;63(3):135-52. doi: 10.1016/j.artmed.2015.02.002. Epub 2015 Feb 16.
4
Sec14-like phosphatidylinositol-transfer proteins and diversification of phosphoinositide signalling outcomes.类Sec14磷脂酰肌醇转移蛋白与磷酸肌醇信号转导结果的多样化
Biochem Soc Trans. 2014 Oct;42(5):1383-8. doi: 10.1042/BST20140187.
5
Structural protein-ligand interaction fingerprints (SPLIF) for structure-based virtual screening: method and benchmark study.用于基于结构的虚拟筛选的结构蛋白-配体相互作用指纹(SPLIF):方法与基准研究
J Chem Inf Model. 2014 Sep 22;54(9):2555-61. doi: 10.1021/ci500319f. Epub 2014 Aug 20.
6
Scoring functions for protein-ligand interactions: a critical perspective.蛋白质-配体相互作用的评分函数:批判性视角
Drug Discov Today Technol. 2004 Dec;1(3):231-9. doi: 10.1016/j.ddtec.2004.08.004.
7
Incorporation of protein flexibility and conformational energy penalties in docking screens to improve ligand discovery.在对接筛选中纳入蛋白质灵活性和构象能量惩罚以改善配体发现。
Nat Chem. 2014 Jul;6(7):575-83. doi: 10.1038/nchem.1954. Epub 2014 May 25.
8
Protein-ligand docking in the new millennium--a retrospective of 10 years in the field.新世纪的蛋白-配体对接——该领域十年回顾。
Curr Med Chem. 2013;20(18):2296-314. doi: 10.2174/0929867311320180002.
9
Using active site mapping and receptor-based pharmacophore tools: prelude to docking and de novo/fragment-based ligand design.运用活性位点映射和基于受体的药效团工具:对接以及从头设计/基于片段的配体设计的前奏。
Methods Mol Biol. 2011;716:39-54. doi: 10.1007/978-1-61779-012-6_3.
10
Advances and challenges in protein-ligand docking.蛋白质-配体对接的进展与挑战
Int J Mol Sci. 2010 Aug 18;11(8):3016-34. doi: 10.3390/ijms11083016.

分子对接:从锁钥模型到组合锁模型

Molecular Docking: From Lock and Key to Combination Lock.

作者信息

Tripathi Ashutosh, Bankaitis Vytas A

机构信息

Department of Molecular and Cellular Medicine, College of Medicine, Texas A&M Health Sciences Center, College Station, Texas, USA.

Department of Biochemistry and Biophysics, A&M Health Sciences Center, Texas, USA.

出版信息

J Mol Med Clin Appl. 2017;2(1). doi: 10.16966/2575-0305.106. Epub 2017 Feb 10.

DOI:10.16966/2575-0305.106
PMID:29333532
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5764188/
Abstract

Accurate modeling of protein ligand binding is an important step in structure-based drug design, is a useful starting point for finding new lead compounds or drug candidates. The 'Lock and Key' concept of protein-ligand binding has dominated descriptions of these interactions, and has been effectively translated to computational molecular docking approaches. In turn, molecular docking can reveal key elements in protein-ligand interactions-thereby enabling design of potent small molecule inhibitors directed against specific targets. However, accurate predictions of binding pose and energetic remain challenging problems. The last decade has witnessed more sophisticated molecular docking approaches to modeling protein-ligand binding and energetics. However, the complexities that confront accurate modeling of binding phenomena remain formidable. Subtle recognition and discrimination patterns governed by three-dimensional features and microenvironments of the active site play vital roles in consolidating the key intermolecular interactions that mediates ligand binding. Herein, we briefly review contemporary approaches and suggest that future approaches treat protein-ligand docking problems in the context of a 'combination lock' system.

摘要

蛋白质配体结合的精确建模是基于结构的药物设计中的重要一步,是寻找新的先导化合物或药物候选物的有用起点。蛋白质 - 配体结合的“锁钥”概念主导了对这些相互作用的描述,并已有效地转化为计算分子对接方法。反过来,分子对接可以揭示蛋白质 - 配体相互作用中的关键要素,从而能够设计针对特定靶点的强效小分子抑制剂。然而,结合构象和能量的准确预测仍然是具有挑战性的问题。过去十年见证了更复杂的分子对接方法用于模拟蛋白质 - 配体结合和能量学。然而,准确建模结合现象所面临的复杂性仍然巨大。由活性位点的三维特征和微环境所支配的微妙识别和区分模式在巩固介导配体结合的关键分子间相互作用中起着至关重要的作用。在此,我们简要回顾当代方法,并建议未来的方法在“密码锁”系统的背景下处理蛋白质 - 配体对接问题。